AI models trained on biased or incomplete data could perpetuate and even amplify existing health disparities, particularly for women.
Outdated research, specifically the 2002 Women's Health Initiative trial, continues to dictate modern medical practice for menopause, leading to suboptimal care.
A significant lack of funding (estimated $200M needed for a new trial) prevents the large-scale research required to update women's health guidelines.
A generation of clinicians lacks proper education on menopause management, leaving patients without access to knowledgeable care.
Opportunities Identified
AI presents a transformative opportunity to accelerate drug development, personalize medicine, and analyze complex, continuous data streams.
Building new, large-scale, inclusive datasets (like the UK Biobank) can correct historical biases in medical research.
Telehealth offers a scalable solution to improve patient access to specialized care, such as certified menopause practitioners.
The growing public conversation around menopause is creating momentum and demand for better research, education, and clinical services.